Skip to main content

Opus Genetics, Inc.

IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001228627

In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Opus Genetics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
37
0 vs. Q2 2022
Shares held
2.83M
+436.6K (+18.3%) vs. Q2 2022
Total value
$5.69M
+$1.10M (+24.0%) vs. Q2 2022
New holders
6
7 more added
Sold out
6
9 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 37 institutions
Q1 2021: 27 institutionsQ2 2021: 36 institutionsQ3 2021: 30 institutionsQ4 2021: 40 institutionsQ1 2022: 41 institutionsQ2 2022: 38 institutionsQ3 2022: 37 institutionsQ4 2022: 35 institutionsQ1 2023: 41 institutionsQ2 2023: 49 institutionsQ3 2023: 50 institutionsQ4 2023: 50 institutionsQ1 2024: 49 institutionsQ2 2024: 37 institutionsQ3 2024: 38 institutionsQ4 2024: 43 institutionsQ1 2025: 46 institutionsQ2 2025: 43 institutionsQ3 2025: 48 institutionsQ4 2025: 59 institutionsQ1 2026: 79 institutionsQ2 2026: 103 institutions
Value heldQ3 2022: $5.69M
Q1 2021: $5.27MQ2 2021: $5.61MQ3 2021: $8.62MQ4 2021: $8.07MQ1 2022: $6.69MQ2 2022: $4.62MQ3 2022: $5.69MQ4 2022: $10.9MQ1 2023: $13.0MQ2 2023: $16.0MQ3 2023: $12.6MQ4 2023: $11.2MQ1 2024: $6.78MQ2 2024: $4.13MQ3 2024: $3.32MQ4 2024: $4.38MQ1 2025: $14.7MQ2 2025: $16.5MQ3 2025: $31.9MQ4 2025: $55.9MQ1 2026: $203.8MQ2 2026: $236.4M
Institutions holding IRD and their total value by quarter
QuarterHoldersValue
Q2 2026103$236.4M
Q1 202679$203.8M
Q4 202559$55.9M
Q3 202548$31.9M
Q2 202543$16.5M
Q1 202546$14.7M
Q4 202443$4.38M
Q3 202438$3.32M
Q2 202437$4.13M
Q1 202449$6.78M
Q4 202350$11.2M
Q3 202350$12.6M
Q2 202349$16.0M
Q1 202341$13.0M
Q4 202235$10.9M
Q3 202237$5.69M
Q2 202238$4.62M
Q1 202241$6.69M
Q4 202140$8.07M
Q3 202130$8.62M
Q2 202136$5.61M
Q1 202127$5.27M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Opus Genetics, Inc.; share changes are against Q2 2022.

Institutions holding IRD in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc703,088$1.41M0.00%00.0%Unchanged
Rice Hall James & Associates, LLC540,348$1.09M0.06%+212,854+65.0%Added
MAI Capital Management356,948$717.0K0.01%+356,948New
Richmond Brothers, Inc.320,332$641.0K0.71%+9,212+3.0%Added
Renaissance Technologies LLC206,901$416.0K0.00%+8,711+4.4%Added
Geode Capital Management, LLC151,569$304.0K0.00%+4,110+2.8%Added
BlackRock Inc.66,717$135.0K0.00%−4,452−6.3%Reduced
State Street Corp62,173$125.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP36,593$74.0K0.00%−8,040−18.0%Reduced
Comerica Bank30,000$68.0K0.00%00.0%Unchanged
Morgan Stanley32,603$66.0K0.00%−2,063−6.0%Reduced
Ameriprise Financial Inc30,099$60.0K0.00%00.0%Unchanged
Eidelman Virant Capital25,000$51.0K0.04%00.0%Unchanged
Dimensional Fund Advisors LP25,576$51.0K0.00%+25,576New
Millennium Management LLC24,463$49.0K0.00%−11,119−31.2%Reduced
Diametric Capital, LP24,548$49.0K0.02%−9,808−28.5%Reduced
Northern Trust Corp22,281$45.0K0.00%00.0%Unchanged
Warberg Asset Management LLC21,000$42.0K0.01%−3,200−13.2%Reduced
Captrust Financial Advisors19,501$39.0K0.00%+18,001+1,200.1%Added
Two Sigma Advisers, LP18,200$37.0K0.00%−134,200−88.1%Reduced
Charles Schwab Investment Management Inc14,928$31.0K0.00%00.0%Unchanged
JPMorgan Chase & Co15,600$31.0K0.00%+15,600New
Bedel Financial Consulting, Inc.15,000$31.0K0.01%+15,000New
Susquehanna Fundamental Investments, LLC15,105$30.0K0.00%+15,105New
Cornerstone Capital, Inc.13,857$28.0K0.00%00.0%Unchanged
Stokes Family Office, LLC12,120$24.0K0.00%00.0%Unchanged
Kestra Private Wealth Services, LLC10,000$20.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)3,392$7.00K0.00%+256+8.2%Added
Wells Fargo & Company2,908$6.00K0.00%+4+0.1%Added
UBS Group AG1,700$3.00K0.00%−766−31.1%Reduced
Capital Analysts, LLC1,636$3.00K0.00%+1,636New
CarsonAllaria Wealth Management, Ltd.1,000$2.00K0.00%00.0%Unchanged
First Manhattan Co600$1.00K0.00%00.0%Unchanged
Aspire Private Capital, LLC400$1.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.48$00.00%−8,723−99.5%Reduced
Royal Bank of Canada5$00.00%00.0%Unchanged
TCI Wealth Advisors, Inc.2$00.00%00.0%Unchanged
Prelude Capital Management, LLC0$00.00%−17,802−100.0%Sold out
Citadel Advisors LLC0$00.00%−16,458−100.0%Sold out
MCF Advisors LLC0$00.00%−10,565−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−10,005−100.0%Sold out
Spire Wealth Management0$00.00%−9,002−100.0%Sold out
Cutler Group LP0$00.00%−200−100.0%Sold out
Frontier Wealth Management LLC––––Not filed